Skin fibroblasts from two cases of autosomal recessive cutis laxa (CL), having insignificant elastin production and mRNA levels, were challenged with transforming growth factor beta-i (TGF-fi1). Elastin production was brought from undetectable values to amounts typical of normal human skin fibroblasts in a dose-dependent fashion. Basic fibroblast growth factor (100 ng/ml) alone or in combination with TGF-,B1 reduced elastin production and mRNA expression in CL skin fibroblasts more extensively than in normal cells. In situ hybridization showed that these effects were at the transcript level. One of the CL strains was examined in detail. Transcription rates for elastin were similar in normal and CL and unchanged by TGF-,fl or TGF-P2 (10 ng/ml), while in CL elastin mRNA half-life was increased > 10-fold by TGF-p2 and reduced 6-fold after TGF-,82 withdrawal, as compared with a control strain. Cycloheximide partially reversed elastin mRNA instability. These data are consistent with a defect in elastin mRNA stability that requires synthesis of labile factors or intact translational machinery, resulting in an extremely low steady state level of mRNA present in this strain of CL. Furthermore, TGF-j3 can relieve elastin mRNA instability in at least one CL strain and elastin production defects in both CL strains. (J. Clin. Invest. 1995. 95:986-994.)
Introduction
Inherited cutis laxa (CL)1 is a rare disease, usually present at birth, with severe skin laxity (1) , and it segregates in an autosomal dominant or recessive manner (1, 2) . In the congenital form, collagen and elastic fibers show ultrastructural abnormalities, with dermal laxity and systemic involvement being more severe in the autosomal recessive form compared with the autosomal dominant form (2) (3) (4) . Acquired CL, on the other hand, often exists as a complication of an inflammatory episode (5, 6) . Morphologic studies of skin biopsies from individuals with congenital CL frequently reveal alterations in the quantity and morphology of elastic fibers, there is often a paucity of elastic fibers or an abnormal organization of the fibers, and the microfibrillar component may appear altered in organization, increased in quantity, or separate from the elastin component (7) (8) (9) (10) . Elastin production, evaluated by a specific ELISA, was reported as very low or nearly undetectable in several CL cases (9) . Northern blot analysis of elastin mRNA levels in these and several other strains was markedly reduced, showing a clear correlation with elastin production in these strains (9, 11 ) .
The elastic fiber provides the elastic properties of many vital tissues of the vertebrate body, including arteries, lung, and dermis. The predominant expression of elastin is developmental and transient (12) . Faulty elastin production in heritable or acquired diseases leads to a loss of elastic recoil, and the resulting impaired integrity of elastic fibers plays a major role in the clinical manifestations of a variety of disorders of connective tissue ( 13, 14) . Structural alterations in elastic fibers can also be detected in acquired conditions, such as pulmonary emphysema, inflammatory vasculitis, and actinic elastosis. Abnormal elastic fibers are also detected in other heritable, dominant disorders including pseudoxanthoma elasticum ( 15 ) , supravalvular aortic stenosis (16, 17) , Marfan syndrome (18) , and Buschke-Ollendorff syndrome ( 19) . The molecular basis of Marfan syndrome is defects in the fibrillin I gene, while supravalvular aortic stenosis appears to arise from large 3' deletions/truncations of one elastin allele.
A number of biological signals can regulate elastin production, including steroid hormones (20) , phorbol ester (21) , and cytokines (22, 23) . At least some forms of CL might be based on altered signal transduction from extracellular mediators. Of the peptide growth factors, TGF-,8 most strongly affects extra-The growth factor TGF-,3 was surprisingly able to reverse the decreased elastin phenotype in elastin-deficient strains, and the effect could be largely attributed to changes in transcript stability.
Methods
Human skin fibroblast cultures. Skin fibroblasts from two CL patients, a 24-mo-old infant (K. T.) and a 6-yr-old child (K. L.), were obtained from upper arm biopsies after appropriate consent (9) . Normal human skin fibroblasts GM4390 (23 yr old), used as a control strain, were obtained from the National Institute of General Medical Science Human Genetic Mutant Cell Repository (Camden, NJ).
Fibroblasts were maintained in 5% C02-95% humidified air at 37°C in DME obtained from Gibco Laboratories (Grand Island, NY) containing Hepes buffer (25 mM, pH 7.6), penicillin (100 U/ml), streptomycin (100 ,ug/ml) and 10-20% heat-inactivated FBS, obtained from Hyclone Labs (Logan, UT). Cells were used at passages 7-11. To reduce assay background in the evaluation of elastin production, cells were fed at confluency with DME, and FBS was switched to 10% newborn calf serum (NBCS). 0-10 ,ug/ml recombinant human TGF-,81 (a gift of Genentech, Inc., South San Francisco, CA) or TGF-,/2 (a gift of Celtrix, Inc., Santa Clara, CA) was added to just-confluent cultures alone or in the presence of 100 ng/ml bFGF (a gift of Synergen, Inc., Boulder, CO). Media were harvested after 48 h, the cell layers were washed with cold PBS, and both samples were stored at -20°C until assays were performed. (29) . Rabbit antiserum to pig a-elastin was used at a 1:4,000 dilution, plates were coated with 40 ng of human a-elastin, and the test was made specific for quantitating soluble tropoelastin (TE) by using a range of 22-0.17 ng/well of pig TE as a competing antigen to construct a standard curve. Data were analyzed by MacReader software obtained from Bio-Rad (Melville, NY). Elastin production was expressed as molecular equivalents/ cell * h. DNA assay. DNA content of confluent cell layers was evaluated by a fluorometric procedure using Hoescht 33258 supplied by Boehringer Mannheim Biochemicals (Indianapolis, IN), as previously described (30, 31) .
In situ hybridization. Two cDNA probes were used: (1) cHE-4, 1.0-kb human elastin cDNA fragment cleaved with BamHI and HindIII from a larger insert in the EcoRI site of a Bluescript plasmid supplied by Stratagene (La Jolla, CA), which corresponds to exons 18-36 of human elastin gene (32); (2) HF1 131, a 1.9-kb collagen type I cDNA insert in the EcoRI site of pBR322 corresponding to the COOH-terminal portion of the pro a2 chain of human type I procollagen (33). We followed a hybridization procedure previously described (34), with some modifications. In brief, slides were pretreated with 0.25% acetic anhydride in 0.1 M triethanolamine, pH 8.0 (10 min, 20°C), denatured with 50% formamide (Fisher Scientific, Pittsburgh, PA) in 2 x SSC (8 min, 60°C), and dehydrated. 40 til of the hybridization solution containing 10,000 dpm/ Ml of the radiolabeled probe was added to the slides which were then covered with siliconized, baked coverslips and sealed. The hybridization was carried on for FF7E 15 h at 40°C followed by washes in 2 x SSC plus 30% formamide and then stringency washes in decreasing concentrations of SSC. Dehydrated slides were dipped in the NTB-2 Kodak autoradiographic emulsion and stored for [8] [9] [10] (37) , and human collagenase (38) . The RNA molecules thus synthesized were hybridized in 7% SDS, 1 mM EDTA, and 250 mM Na2PO4 at 65°C for 48 h. In an earlier experiment, cells were treated with 10 ng/ml TGF-/31, and the RNA molecules were hybridized to 10 Htg plasmid DNA containing all the cDNA inserts just described except for TNF-ca and human collagenase. The filters were washed twice for 30 min each in 1 mM EDTA, 40 mM Na2HPO4, pH 7.2, 5% SDS at 65°C and incubated at 37°C in 2 x SSC with 10 jg/ml RNase A (Sigma Chemical Co.) for 30 min. The filters were then washed twice in 1 mM EDTA, 40 mM Na2HPO4, 1% SDS at 65°C for 30 min. Autoradiography to detect hybridizable transcripts was for 5-7 d with an intensifying screen. The optical densities of autoradiographic signals for each transcript were normalized to that for GAPDH, and the transcription values were calculated as the ratio of each transcript signal relative to the GAPDH signal.
mRNA half-life. Confluent CL strain K. T. cells were pretreated with 10 ng/ml TGF-,62 in DME, 10% FBS for 48 h and then washed three times with PBS. Fresh media with or without 10 ng/ml TGF-,62, containing 60 uM 5,6-dichlorobenzimidazole riboside (DRB; reference 25) , supplied by Sigma Chemical Co., from a stock solution of 20 mM in isopropanol, was added to cultures (t = 0). Control fibroblasts, GM4390, were treated with the cytokine at t = 0 together with DRB. 6, 12, and 24 h after addition of DRB, cells were washed twice in PBS buffer and lysed in 2 ml 4 M guanidine isothiocyanate containing 0.1 mM /i-mercaptoethanol. DNA was sheared by passage three times through a 22-gauge needle, and RNA was isolated by extraction in acid phenol/chloroform (39 Figure 1 . Effect of growth factors on TE production in normal (GM4390) and CL (K. T.; K. L.) fibroblast strains. Fibroblasts in 8-well culture-chamber slides were fed at confluency with 300 ,tl DME, 10% NBCS, and increasing amounts (0, 0.1, 1.0, and 10.0 ng/ ml) of TGF-,61 in the presence or absence of 100 ng/ml bFGF. Media were harvested after 48 h, and elastin production was evaluated by an ELISA. Data are expressed as molecular equivalents produced per cell per hour ± SEM. mRNA expression was normalized to cyclophilin or the staining intensity of the 28S ribosome band.
Calculation of decay kinetics was based on a logarithmic transformation of initial decay rates (0-12 h) for each treatment group, and the slopes of the regression lines were used to estimate t1/2. Significance of differences between control and K. T. mRNAE stability could be tested by pooling the data and using the slopes of the decay curves and the standard error of the regression estimate to calculate a value of t.
Elastin mRNA decay kinetics after withdrawal of TGF-f3. Confluent cultures of K. T. and GM4390 fibroblast strains were treated for 2 d with 10 ng/ml of TGF-,l2 in DME containing 10% FBS. Cells were washed 5x with PBS, and refed with fresh DME, 10% FBS. 2 
Results
Upregulation of elastin in CL strains by TGF-/3. Cultured fibroblasts were grown to confluency and then incubated with DME, 10% NBCS containing 0-10 ng/ml of TGF-,61 with or without 100 ng/ml of bFGF. As previously observed, elastin production in the CL fibroblast strains under standard culture conditions was negligible or below the level of detection of the ELISA assay (Fig. 1) . When TGF-,B was added to K. T. and K. L. cultures, elastin accumulation in these cell strains was strongly stimulated, bringing production from undetectable values to one third of the level of normal production in strain K. T.
and to values similar to those of normal skin fibroblasts in strain K. L.
Under standard culture conditions, the addition of 100 ng/ ml bFGF to the control strain reduced elastin production by about twofold. In the presence of the same concentration of bFGF, the TGF-,6-dependent stimulation of elastin production was strongly inhibited in CL strains K. L. and K. T. The degree of reduction in the two CL strains was much greater than that of the normal strain, elastin production being reduced to undetectable values for strain K. T., and approximately eightfold in strain K. L. (Fig. 1 ) .
Elastin mRNA (mRNAE) levels and the homogeneity of the cellular response to cytokines were assessed by in situ hybridization. In the cells from a normal donor (Fig. 2, NORMAL) , substantial expression of mRNAE could be seen even in the absence of TGF-,81 in the medium. By contrast, cells from the patient K. T. (Fig. 2 , CUTIS LAXA) presented a very low number of silver grains per cell. The administration of increasing concentrations of TGF-,31 (0-10 ng/ml) brought about a progressive, dose-dependent increase in mRNAE accumulation in both cell strains. Reduced transcript abundance was brought about by the addition of bFGF (100 ng/ml) to these strains.
In Fig. 3 normal and CL cells were hybridized with a probe for COL1A2 mRNA. There were no remarkable differences in transcript abundance in normal and CL strains (also see Fig.   5 ), TGF-,6 stimulated collagen type I mRNA accumulation in both strains, and this stimulation was partially reversed by the addition of bFGF (100 ng/ml).
Reduced elastin mRNA in CL strain K. T. is not attributable to transcription. To determine further the mechanism for reduced steady-state levels of mRNAE in strain K. T., nuclear run-on transcription studies were performed (Fig. 4) The rescue of TE production by TGF-/6 is associated with transient stabilization of mRNAE in K. T. strain. Since we observed no significant difference in elastin transcription between a normal and a CL cell strain, these data suggested a defect in elastin expression at a posttranscriptional level. To assess if this mechanism involved degradation of mRNAE, we studied the decay kinetics of this transcript. Since mRNAE was only accumulated in K. T. cells after TGF-,6 stimulation, the decay of elastin mRNA K. T. cells was followed after pretreatment with 10 ng/ml TGF-f3. Subsequently, new transcription was shut off by adding DRB, and mRNA decay was followed, with and without withdrawal of TGF-P2, by Northern blot hybridization. (18x; Fig. 5 ). In control cells, the mRNAE was much more stable, with a tl12 of FF7E 8 h in this system. This betweenstrain difference in half-lives in the presence of TGF-f3 corresponded well to differences in elastin accumulation (Fig. 1) Table I . regression lines showed highly significant differences in these rates (P < 0.01, t test). In the set of cultures in Fig. 6 This treatment slowed the mRNAE decay in both normal and CL fibroblast strains, although mRNAE decay in the CL strain was already nearly complete. At day 4, mRNAE was 140% higher in controls and 10% higher in K. T. cells treated with CHX. To confirm the decay and CHX effects, CHX was added to another set of cultures at the time of withdrawal of TGF-/32, and this earlier blockage of protein synthesis markedly reduced mRNAE decay. By scanning densitometry of the autoradiogram, we found that the presence of CHX in K. T. cultures increased mRNAE levels by 250% at day 1 and 75% at day 2 relative to cultures grown in the absence of the drug (Fig. 6 B, inset) .
Discussion
In a subset of CL patients with severe, congenital onset of symptoms, affected individuals present with wrinkled and sagging skin, giving the appearance of premature aging, as well as having internal organ involvement. In the most severely affected individuals, elastic fibers are either absent or severely deranged in the skin as well as other elastic structures. Severely affected individuals often succumb to pulmonary failure in the first few years of life. In a previous study by Sephel et al. (9) it was shown that, although heterogeneity exists among individuals in the capacity of their skin fibroblasts to produce elastin, reduced elastin production is a distinctive feature of at least some CL 4 6 to interact under a number of circumstances (23, (48) (49) (50) These findings suggest that the defect in CL, at least in K. T., involves subtle changes in the structure of mRNAE rather than truncation of one ELN allele, as appears to be the case in supravalvular aortic stenosis (16) . Alternatively, CL cells may lack factors that normally protect mRNAE from degradation, or they may overexpress mRNAE degrading activities. Isolation and detailed characterization of regions involved in posttranscriptional processing of mRNA are being undertaken to determine whether defects in ELN transcripts can be identified by either direct structural or functional assays.
Degradation of mRNAE in K. T. cells is markedly reduced by TGF-j, reinforcing the concept that normal and abnormal regulation of elastin production is frequently controlled posttranscriptionally (46) . Since continued protein synthesis appears to be required to degrade mRNAE after TGF-,/ withdrawal, it appears that either the mRNA degrading factors themselves are labile proteins or that mRNA degradation is a cotranslational process. Although CL is a rare syndrome, in vitro correction of an elastin synthetic defect could point to the rational application of molecules like TGF-,3 as therapeutic agents in this and other regulatory mutations of connective tissue molecules.
